✦ LIBER ✦

E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer

✍ Scribed by Mohamed Hebbar; Antoine Adenis; Françoise Révillion; Alain Duhamel; Olivier Romano; Stéphanie Truant; Christian Libersa; Claire Giraud; Jean-Pierre Triboulet; François-René Pruvot; Jean-Philippe Peyrat

Book ID: 116430015
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 172 KB
Volume: 45
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2009.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KRASMutation is Associated with Worse Pr

KRASMutation is Associated with Worse Prognosis in Stage III or High-risk Stage II Colon Cancer Patients Treated with Adjuvant FOLFOX

✍ Lee, Dae-Won; Kim, Kyung Ju; Han, Sae-Won; Lee, Hyun Jung; Rhee, Ye Young; Bae, 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 351 KB

Impact of HLA-E gene polymorphism on HLA

Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer

✍ Zi-Jun Zhen, Jia-Yu Ling, Yue Cai, Wen-Biao Luo, You-Jian He 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 508 KB

The collagenase-1 (MMP-1) gene promoter

The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer

✍ Hettiaratchi, A; Hawkins, N J; McKenzie, G; Ward, R L; Hunt, J E; Wakefield, D; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 280 KB

A mutant TP53 gene status is associated

A mutant TP53 gene status is associated with a poor prognosis and anthracycline-resistance in breast cancer patients

✍ E Rahko; G Blanco; Y Soini; R Bloigu; A Jukkola 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 138 KB

RKIP phosphorylation and STAT3 activatio

RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients

✍ Cross-Knorr, Sam; Lu, Shaolei; Perez, Kimberly; Guevara, Sara; Brilliant, Kate; 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 668 KB

Tumor dihydropyrimidine dehydrogenase in

Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone

✍ Takashi Tsuji; Terumitsu Sawai; Hiroaki Takeshita; Tohru Nakagoe; Shigekazu Hida 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 130 KB